SYK
Stryker Corporation
327.81
120 x undefined
40 x undefined
bid
ask
-
1.64
0.50%
80 @ 07:54 PM
327.54 -0.27 (0.08%)
Ytd-6.73%
1y-16.85%
327.01
day range
334.87
281.00
52 week range
396.86
Open330.00Prev Close329.45Low327.01High334.87Mkt Cap125.74B
Vol1.88MAvg Vol2.59MEPS9.60P/E34.15Forward P/E19.57
Beta0.77Short Ratio3.30Inst. Own82.76%Dividend3.52Div Yield1.07
Ex Div Date09-30Earning10-2950-d Avg326.60200-d Avg340.481yr Est382.72
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-292026-093.63N/AN/AN/A
2026-07-302026-063.493.690.25.73%
2026-04-302026-032.982.6-0.38-12.75%
2026-01-292025-124.44.470.071.59%
2025-10-302025-093.133.190.061.92%
2025-07-312025-063.073.130.061.95%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-13Wolfe ResearchDowngradeOutperformPeer Perform
2026-08-03CitizensUpgradeMarket OutperformMarket Outperform
2026-07-31RBC CapitalUpgradeOutperformOutperform
2026-07-31JP MorganUpgradeOverweightOverweight
2026-07-31Piper SandlerUpgradeOverweightOverweight
2026-07-31Truist SecuritiesUpgradeHoldHold
Profile
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Insider Holder
DateNameRelationQuantityDescription
2025-03-20BECKER YIN COfficer36.05KConversion of Exercise of derivative security
2025-03-20BOEHNLEIN GLENN SChief Financial Officer13.20KConversion of Exercise of derivative security
2026-05-10FINK MARY KATHRYNOfficer0.00Sale
2025-02-17GOLSTON ALLAN CDirector14.90KSale
2026-03-19LOBO KEVIN AChief Executive Officer222.95KConversion of Exercise of derivative security
2026-03-19MENON VIJU SOfficer17.58KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.27.41M8.99B7.15%
2026-06-29Vanguard Capital Management LLC22.54M7.39B5.88%
2026-06-29JPMORGAN CHASE & CO17.26M5.66B4.50%
2026-06-29State Street Corporation15.53M5.09B4.05%
2026-06-29Greenleaf Trust15.23M4.99B3.97%
2026-06-29Price (T.Rowe) Associates Inc11.92M3.91B3.11%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund10.94M3.58B2.85%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund8.75M2.87B2.28%
2026-06-29iShares Trust-iShares Core S&P 500 ETF4.76M1.56B1.24%
2026-06-29Fidelity Concord Street Trust-Fidelity 500 Index Fund4.43M1.45B1.15%
2026-06-29SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust4.17M1.37B1.09%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Growth Index Fund3.77M1.24B0.98%
Dividend
DividendDate
0.882026-09-30
0.882026-06-30
0.882026-03-31
0.882025-12-31
0.842025-09-30
0.842025-06-30
Split
SplitDate
2 : 12004-05-17
2 : 12000-05-15
2 : 11996-06-11
2 : 11991-06-14
3 : 21989-06-20
2 : 11987-06-12